CooperVision Inc.
$6.2M 29,989 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Davol Inc.
Davol Inc. reported $6,173,430.84 across General Payments, Research, and Ownership to 12,178 physicians and teaching hospitals across 12,229 transactions.
- $6.2M
- All-tracks total
- 12,229
- Transactions
- 12,178
- Recipients
- +$1.2M
- General Payments vs PY2023
Davol Inc. reported $6,173,430.84 across all CMS Open Payments tracks (General + Research + Ownership) to 12,178 physicians and teaching hospitals in Program Year 2024 - ranking #236 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $4,351,191.70, averaging $506.93 per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer davol-inc Davol Inc.
$6.2M · #236/1,925 · 0.0% industry · PY2024
- TOT $6.2M
- RANK #236
- SHARE 0.0%
- TXN 12,229
- RCP 12,178
- CAT 9
- GEN $4.4M
- ΔGEN +$1.2M
- TOP1 10.8%
- PY 2024
Volume peers
Nearest volume peer: CooperVision Inc. ($6.2M)
Davol Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Davol Inc.'s CMS-reported General Payments increased by $1.2M (+36.0%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: DAVOL INC.PY2023: DAVOL INC.PY2024: Davol Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $3,198,820.40
- PY2024
- $4,351,191.70
What the Data Shows for Davol Inc.
$6,173,430.84: that is what Davol Inc. reported in payments to 12,178 physicians and teaching hospitals during Program Year 2024, spread across 12,229 transactions ($504.82 per transaction, $506.93 per recipient). The company sits at rank #236 of 1,925, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.
Of the 9 general-payment categories charted below, "Honoraria" is the largest at $1.8M across 448 transactions, 42.4% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Davol Inc. made 9 types of general payments. "Honoraria" is the largest category at $1.8M, 42.4% of General Payments.
Davol Inc. reports 9 general-payment categories - the top three are Honoraria (42.4%), Debt Forgiveness (18.5%), and Food and Beverage (15.7%). The remaining 6 categories make up 23.3% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
Category breadth matters here: Davol Inc. files across 9 named CMS general-payment types in Program Year 2024, versus manufacturers that report a single dominant category. The chart and table below enumerate every type with an amount above zero for this company.
How Davol Inc. divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Honoraria | $1.8M | 448 | 42.4% |
| Debt Forgiveness | $805.2K | 17 | 18.5% |
| Food and Beverage | $684.6K | 9,805 | 15.7% |
| Travel and Lodging | $441.1K | 1,696 | 10.1% |
| Consulting Fee | $398.7K | 151 | 9.2% |
| Royalty or License | $83.0K | 5 | 1.9% |
| Space Rental or Facility Fees | $50.1K | 5 | 1.2% |
| Compensation for Services Other Than Consulting | $29.9K | 7 | 0.7% |
| Education | $12.2K | 44 | 0.3% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $1,447,624.22 (33.3%) of $4,351,191.70 in this company's General Payments records across 6,338 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Davol Inc.
The five named recipients with the highest reported General Payments from this company
- 1
John Fischer
$468,407.18 across 319 reported transactions
- 2
Mountain Vista Medical Center
$407,245.21 across 4 reported transactions
- 3
Wadley Regional Medical Center
$226,645.58 across 3 reported transactions
- 4
Javad Parvizi
$199,180.64 across 137 reported transactions
- 5
Kristopher Lybarger
$146,145.61 across 130 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Davol Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Davol Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Davol Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Sobi, Inc
$6.1M 16,390 recipients
Compare payment profiles
Agios Pharmaceuticals, Inc.
$6.1M 3,134 recipients
Compare payment profiles
Roche Products Limited
$6.1M 124 recipients
Compare payment profiles
Dental Buying Power LLC
$6.2M 0 recipients
Compare payment profiles
PharmaEssentia USA Corporation
$6.3M 4,725 recipients
Compare payment profiles
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.